The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Adline Chem Lab Ltd

Adline Chem Lab Ltd

BSE 524604 · NSE ADLINE · ISIN INE276T01018 · Group P · Suspended

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹12.28

+4.96%

BSE close, 28 August 2026

Market cap

₹7.18 cr

0.6 cr shares · Micro cap

Free float

₹5.33 cr

as published

P/E · P/B

-37.2× · -4.55×

EPS ₹-0.33 · BV ₹-2.70

FY25-26 rev / PAT

— / -0.28

₹ cr, as filed

Filings, window

13

3 selected · 23%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹7.60 52-WK HIGH ₹17.06 ₹12.28 49% of range
Against 52-week high-28.0%
Against 52-week low+61.6%
Day change+4.96%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-0.33
Price / earnings-37.21×
Price / book-4.55×
Book value — derived, price ÷ P/B₹-2.70
Return on equity12.07%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
12.23%
ROE as published
12.07%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q — 0.04 0.07 — —
Mar-26 · Q — -0.09 -0.17 — —
FY25-26 — -0.28 -0.48 — —

Quarter on quarter

Net profit, quarter on quarter
+144.4%

Disclosure profile 13 filings in the window

0 median 17.0 p75 · 25 sector max 52 13 34th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome2
Results1
Selected sub-total3
Procedural
AGM / EGM3
Board Meeting2
Newspaper Publication2
Annual Report1
Outcome1
Trading Window1
Procedural sub-total10
Total13

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group P, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

13 filings · 3 selected · busiest 2026-08-13 and 2026-09-03

Filing rhythm · the twelve most recent

2026-08-132026-09-29

SelectedProcedural

Filings

13 in the window · 3 earlier on record

  1. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting Results under Regulation 44 of SEBI (LODR) Regulation, 2015 of the Business transacted at the AGM held on 28th September, 2026.

    AGM/EGM / AGM View filing →

  2. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Summary of the Proceeding of 38th Annual General Meeting of the Company held on Monday, 28th September, 2026.

    AGM/EGM / AGM View filing →

  4. 4 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement for AGM

    Company Update / Newspaper Publication View filing →

  5. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report of the Company for the Financial Year 2025-26 along with the Notice of 38th Annual General Meeting to be held on Monday, September 28, 2026, at 02:00 P.M. through Video Conference ....

    Others / Reg. 34 (1) Annual Report View filing →

  6. 3 September 2026 ·

    AGM / EGM

    Notice Of 38Th Annual General Meeting Of Adline Chem Lab Limited Scheduled To Be Held On Monday, September 28, 2026.

    Notice of 38th Annual General Meeting of Adline Chem Lab Limited.

    AGM/EGM / AGM View filing →

  7. 1 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome For Board Of Directors Meeting Held On Tuesday 01St September, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Outcome for Board Of Directors Meeting Held On Tuesday 01st September, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Others / Outcome without intimation View filing →

  8. 27 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Of Directors Meeting Held On Thursday 27Th August, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Convening of the 38th Annual General Meeting (AGM) and other allied matters.

    Board Meeting / Outcome of Board Meeting View filing →

  9. 24 August 2026 ·

    Board Meeting

    Board Meeting Intimation for 38Th Annual General Meeting

    Adline Chem Lab Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 ,inter alia, to consider and approve the day, date, time of 38th ....

    Board Meeting / Board Meeting View filing →

  10. 14 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisment for Extract of Unaudited Standalone Financial Results for the Quarter ended 30th June 2026.

    Company Update / Newspaper Publication View filing →

  11. 13 August 2026 ·

    Results

    Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026.

    unaudited Stanalone Financial Results of the Company for the Quarter Ended June 30, 2026.

    Result / Financial Results View filing →

  12. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Meeting Outcome For Adline Chem Lab Limited For Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026.

    Board Meeting Outcome for Adline Chem Lab Limited for Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  13. 10 August 2026 ·

    Board Meeting

    Board Meeting Intimation for For Considering And Approving Un-Audited Standalone Financial Results For The Quarter Ended On 30.06.2026.

    Adline Chem Lab Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Un-audited Standalone Financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Adline Chem Lab Ltd · the 50 most recent filings